Breaking News Instant updates and real-time market news.

ADVM

Adverum Biotechnologies

$6.15

0.3 (5.13%)

17:30
08/29/18
08/29
17:30
08/29/18
17:30

Adverum Biotechnologies says IND active for ADVM-022

Adverum Biotechnologies announced its Investigational New Drug application is active for the planned multi-center, open-label, Phase 1, dose-escalation study of ADVM-022, a novel gene therapy candidate for the treatment of wet age-related macular degeneration. "We are excited to have this IND active for ADVM-022, currently the only intravitreal gene therapy candidate entering the clinic for patients with wet AMD," said Leone Patterson, interim president and chief executive officer of Adverum Biotechnologies. "We have partnered with leading retinal specialists in the U.S. and look forward to initiating the new OPTIC clinical trial in the fourth quarter of this year."

ADVM Adverum Biotechnologies
$6.15

0.3 (5.13%)

10/12/17
RAJA
10/12/17
INITIATION
Target $6
RAJA
Outperform
Adverum Biotechnologies initiated with an Outperform at Raymond James
Raymond James analyst Reni Benjamin initiated Adverum Biotechnologies with an Outperform and $6 price target due to negative enterprise value and multiple product candidates slated to enter the clinic near-term.
02/15/18
PIPR
02/15/18
INITIATION
Target $12
PIPR
Overweight
Adverum Biotechnologies assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Charles Duncan assumed coverage of Adverum Biotechnologies with an Overweight rating and $12 price target. The analyst believes the company has a "differentiated, risk-mitigated approach" in gene therapy and sees the stock as a "clear value buy."
05/18/18
PIPR
05/18/18
INITIATION
Target $12
PIPR
Overweight
Adverum Biotechnologies assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Tyler Van Buren assumed coverage of Adverum Biotechnologies with an Overweight rating and $12 price target. The analyst says he appreciates the company's "straightforward approaches to gene therapy that utilize well-validated mechanisms and improved vectors." Each of the company's programs have disruptive potential and target large $1B-plus global markets, he contends.
08/09/18
PIPR
08/09/18
NO CHANGE
Target $12
PIPR
Overweight
Adverum shares trade at 'unreasonably low level,' says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren believes the recent pullback in shares of Adverum Biotechnologies has brought the stock to an "unreasonably low level." A $50M enterprise value is unreasonable for a company with three attractive gene therapy approaches in development, Van Buren tells investors in a research note. He expects Adverum shares to "recover significantly" from these levels as a new CEO is announced and the three programs continue to progress in the clinic. The analyst reiterates an Overweight rating on Adverum with a $12 price target.

TODAY'S FREE FLY STORIES

GLD

SPDR Gold Shares

$117.55

-0.13 (-0.11%)

18:05
12/11/18
12/11
18:05
12/11/18
18:05
Hot Stocks
SPDR Gold Shares holdings rise to 763.56MT from 760.32MT »

This is the third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

, SPX

S&P 500

$0.00

(0.00%)

18:04
12/11/18
12/11
18:04
12/11/18
18:04
Periodicals
Breaking Periodicals news story on SPDR S&P 500 ETF Trust, S&P 500 »

Huawei CFO Meng granted…

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIEGY

Siemens

$0.00

(0.00%)

17:56
12/11/18
12/11
17:56
12/11/18
17:56
Periodicals
Siemens to close Texas turbines facility, dismiss 200 workers, Reuters says »

Siemens intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CABO

Cable One

$871.98

9.68 (1.12%)

17:56
12/11/18
12/11
17:56
12/11/18
17:56
Hot Stocks
Cable One to rebrand as Sparklight in the summer of 2019 »

Cable One announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJRD

Aerojet Rocketdyne

$35.40

0.02 (0.06%)

17:53
12/11/18
12/11
17:53
12/11/18
17:53
Hot Stocks
Aerojet Rocketdyne awarded DARPA contract to design OpFires propulsion system »

Aerojet Rocketdyne said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGNC

AGNC Investment

$17.92

0.045 (0.25%)

17:45
12/11/18
12/11
17:45
12/11/18
17:45
Hot Stocks
AGNC Investment reports tangible net book value of $16.76 per share »

AGNC Investment …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$120.40

-0.47 (-0.39%)

, PCRFY

Panasonic

$0.00

(0.00%)

17:40
12/11/18
12/11
17:40
12/11/18
17:40
Periodicals
Breaking Periodicals news story on Toyota, Panasonic »

Panasonic to supply…

TM

Toyota

$120.40

-0.47 (-0.39%)

PCRFY

Panasonic

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDAQ

Nasdaq

$87.28

0.08 (0.09%)

17:37
12/11/18
12/11
17:37
12/11/18
17:37
Hot Stocks
Nasdaq acquires Quandl to 'advance' the use of alternative data »

Nasdaq announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KL

Kirkland Lake Gold

$24.36

0.58 (2.44%)

17:36
12/11/18
12/11
17:36
12/11/18
17:36
Hot Stocks
Kirkland Lake Gold raises dividend to C$0.04 from C$0.03 »

Kirkland Lake Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$36.55

0.41 (1.13%)

, EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

17:26
12/11/18
12/11
17:26
12/11/18
17:26
Periodicals
Breaking Periodicals news story on Boston Scientific, Edwards Lifesciences »

Boston Scientific wins…

BSX

Boston Scientific

$36.55

0.41 (1.13%)

EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

HUSA

Houston American Energy

$0.22

0.0009 (0.42%)

17:26
12/11/18
12/11
17:26
12/11/18
17:26
Syndicate
Breaking Syndicate news story on Houston American Energy »

Houston American Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTVT

vTv Therapeutics

$1.86

0.02 (1.09%)

17:18
12/11/18
12/11
17:18
12/11/18
17:18
Hot Stocks
vTv Therapeutics initiates restructuring, will cut roughly 65% of workforce »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLMD

Galmed

$7.94

-0.445 (-5.31%)

17:18
12/11/18
12/11
17:18
12/11/18
17:18
Initiation
Galmed initiated  »

Galmed initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$114.69

1.8 (1.59%)

17:17
12/11/18
12/11
17:17
12/11/18
17:17
Initiation
Madrigal Pharmaceuticals initiated  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VKTX

Viking Therapeutics

$9.47

0.01 (0.11%)

17:17
12/11/18
12/11
17:17
12/11/18
17:17
Initiation
Viking Therapeutics initiated  »

Viking Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COT

Cott Corp.

$14.68

0.03 (0.20%)

17:14
12/11/18
12/11
17:14
12/11/18
17:14
Hot Stocks
Cott approves $50M share repurchase program »

Cott announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEOS

Neos Therapeutics

$2.03

-0.08 (-3.79%)

17:11
12/11/18
12/11
17:11
12/11/18
17:11
Syndicate
Breaking Syndicate news story on Neos Therapeutics »

Neos Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$104.73

-1.32 (-1.24%)

17:10
12/11/18
12/11
17:10
12/11/18
17:10
Initiation
Intercept initiated  »

Intercept initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOCA

Tocagen

$12.85

0.2 (1.58%)

17:10
12/11/18
12/11
17:10
12/11/18
17:10
Syndicate
Tocagen files to sell 3M shares of common stock »

Citigroup and Leerink…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCS

OncoSec

$0.82

-0.0489 (-5.62%)

17:09
12/11/18
12/11
17:09
12/11/18
17:09
Hot Stocks
Breaking Hot Stocks news story on OncoSec »

Alpha Holdings raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISBC

Investors Bancorp

$11.48

-0.06 (-0.52%)

17:09
12/11/18
12/11
17:09
12/11/18
17:09
Hot Stocks
Investors Bancorp announces balance sheet restructure, branch rationalization »

Investors Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVDL

Avadel Pharmaceuticals

$2.62

0.06 (2.34%)

17:05
12/11/18
12/11
17:05
12/11/18
17:05
Hot Stocks
Broadfin Capital reports 8.4% stake in Avadel Pharmaceuticals »

Broadfin Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$319.85

0.22 (0.07%)

16:58
12/11/18
12/11
16:58
12/11/18
16:58
Conference/Events
Biogen to hold a conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RSYS

RadiSys

$1.72

(0.00%)

16:58
12/11/18
12/11
16:58
12/11/18
16:58
Syndicate
RadiSys requests withdrawal of registration statement »

The company is applying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

LDOS

Leidos

$58.65

-0.82 (-1.38%)

, MSFT

Microsoft

$108.67

1.11 (1.03%)

16:51
12/11/18
12/11
16:51
12/11/18
16:51
Hot Stocks
Leidos to collaborate with Microsoft on government and commercial cloud clients »

Leidos (LDOS) announced…

LDOS

Leidos

$58.65

-0.82 (-1.38%)

MSFT

Microsoft

$108.67

1.11 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.